Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916131 · ClinicalTrials.gov registry record · NA
Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management.
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05916131 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 40 participants.
The verdict
NCT05916131, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
A mobile health program "HypoPals", which incorporates data from continuous glucose monitoring systems (CGMs) and sends personalized text messages to help people sharpen their low blood sugar symptom detection skills, and help people consider how they think of low blood sugar, was devised. The goal of the current study is to make sure that HypoPals runs smoothly, users find the intervention useful, and the way the researchers conduct the final study will be correct (i.e., there is a need for 'pilot testing' the developed technology and research methods). All participants will receive basic hypoglycemia education text messages, and then be randomized to one of the four experimental conditions: Hypoglycemia Symptom Detection Training, Education Plus, both Symptom Detection Training and Education Plus, and usual care. Participants may receive additional interventional text messages based on the experimental condition participants are assigned to. The study may terminate after collecting sufficient data to evaluate the primary outcome (i.e., determining the number of participants recruited to reach 20 participants who complete the intervention).
Interventions
- BEHAVIORAL Basic Education
- BEHAVIORAL Hypoglycemia Symptom Detection Training
- BEHAVIORAL Education Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2025-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05916131
The ClinicalTrials.gov registry entry for NCT05916131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Basic Education is the first listed.
NCT05916131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05916131 about?
NCT05916131 is a clinical study titled "Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management.". A mobile health program "HypoPals", which incorporates data from continuous glucose monitoring systems (CGMs) and sends personalized text messages to help people sharpen their low blood sugar symptom detection skills, and help people consider how they think of low blood sugar, was devised. The goal ...
What is the current status of trial NCT05916131?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-19. Estimated completion is 2025-02-12.
What interventions are being tested in trial NCT05916131?
The interventions under investigation include: Basic Education (BEHAVIORAL), Hypoglycemia Symptom Detection Training (BEHAVIORAL), Education Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT05916131?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.